LigaChem Biosciences Inc 141080
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 68,100.00
- Day Range
- KRW 67,800.00–71,000.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 67,900.00 / KRW 68,000.00
- Market Cap
- KRW 2.45 Tril
- Volume/Avg
- 1,895 / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 52.69
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.20%
Company Profile
LigaChem Biosciences Inc formerly LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Value
- Total Number of Employees
- 144
- Website
- http://www.legochembio.com
Comparables
Valuation
|
Metric
|
141080
|
085660
|
174900
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 12.98 | 3.41 | 10.17 |
Price/Sales | 52.69 | 1.06 | 82.12 |
Price/Cash Flow | — | 36.24 | — |
Price/Earnings
141080
085660
174900
Financial Strength
|
Metric
|
141080
|
085660
|
174900
|
|---|---|---|---|
Quick Ratio | 3.21 | 0.73 | 1.01 |
Current Ratio | 3.63 | 0.83 | 1.10 |
Interest Coverage | −153.38 | 0.67 | −9.08 |
Quick Ratio
141080
085660
174900
Profitability
|
Metric
|
141080
|
085660
|
174900
|
|---|---|---|---|
Return on Assets (Normalized) | −30.49% | −0.51% | −23.71% |
Return on Equity (Normalized) | −37.86% | −2.90% | −39.44% |
Return on Invested Capital (Normalized) | −36.75% | 0.33% | −26.14% |
Return on Assets
141080
085660
174900
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hkjhwyfjdj | Xmck | $559.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Ybvbzbmyy | Vrmytf | $103.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Pjddxlv | Zjlgk | $103.3 Bil | |
MRNA
| Moderna Inc | Zhkbvzph | Tcx | $42.7 Bil | |
ARGX
| argenx SE ADR | Kyctjbw | Jybqk | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Qbrxywhvl | Lfdhv | $21.7 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ryfylmx | Gmdrpn | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Hxnzzfk | Pwgph | $15.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Qnntjffj | Mkbhlj | $12.7 Bil | |
INCY
| Incyte Corp | Lwmvjykx | Klhfxv | $11.9 Bil |